Drew Angerer/Getty Images
- OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging.
- His anti-aging regimen also includes healthy eating, exercising, and getting enough sleep.
- He's secretly invested in Retro Biosciences, a startup whose mission is to "add 10 years to healthy human lifespan."
Sam Altman, the CEO of ChatGPT-maker OpenAI, takes a diabetes drug called metformin as part of his efforts to live longer, the MIT Technology Review reported.